BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KvinnoKapital - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.kvinnokapital.com
X-WR-CALDESC:Events for KvinnoKapital
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20260915T113000
DTEND;TZID=Europe/Stockholm:20260915T130000
DTSTAMP:20260610T164229
CREATED:20260609T142448Z
LAST-MODIFIED:20260609T142448Z
UID:6433-1789471800-1789477200@www.kvinnokapital.com
SUMMARY:Upcoming: Lunch session with Linden Thomson\, Investing in the fight against cancer
DESCRIPTION:Investing in the Fight Against Cancer: Impact Beyond Returns \nIn a world shaped by demographic ageing\, rapid scientific progress\, and rising healthcare needs\, oncology stands out as one of the most impactful long-term investment themes. In this session\, Linden Thomson will share her personal career journey as one of the early women in biotech investing\, reflecting on leadership\, diversity\, and the challenges she faced in building a career in a competitive\, male-dominated sector. She will also discuss how thematic investing in healthcare\, particularly oncology\, can generate sustainable financial returns while driving meaningful societal progress\, illustrating how investment capital can accelerate medical advances that support early detection\, enable personalised medicine\, and improve patient outcomes. \nCandriam further amplifies this impact by donating 10% of management fees from oncology investments to cancer foundations across the countries where investors are based\, turning capital into tangible societal benefit. \nBiography \nLinden Thomson is a Portfolio Manager at Candriam\, specialising in biotechnology and oncology. She began her career in the medical field\, earning a BSc (Hons) in Medical Microbiology from the University of Edinburgh\, before transitioning into asset management\, where she became one of the few early movers in healthcare and biotechnology investing. Starting at Goldman Sachs in 2003\, she built deep expertise in healthcare\, later joining a biotech hedge fund at start-up stage\, and then AXA Investment Managers\, where she was Lead Manager of the Framlington Biotech fund\, Head of the Healthcare Franchise\, and member of the UK Executive Committee. \nWith over 20 years of experience bridging science and investment\, Linden’s journey demonstrates how curiosity\, perseverance\, and cross-disciplinary skills opened unique opportunities to shape her career at the intersection of science\, finance\, and impact investing. \n  \n 
URL:https://www.kvinnokapital.com/event/upcoming-lunch-session-with-linden-thomson-investing-in-the-fight-against-cancer/
ATTACH;FMTTYPE=image/jpeg:https://www.kvinnokapital.com/wp-content/uploads/2026/06/Linden-Thomson-Web-2-scaled.jpg
END:VEVENT
END:VCALENDAR